Author of

• 16722

  +

  P1.04 - Poster Session with Presenters Present (ID 456)

  • Event: WCLC 2016
  • Type: Poster Presenters Present
  • Track: Pulmonology
  • Presentations: 1
  • Moderators:
  • Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)

  • 16739

    +

    P1.04-017 - The Survival of Our Patients Diagnosed with Lung Cancer in 2013 (ID 5187)

    14:30 - 14:30  |  Author(s): S. Hastürk
    • Abstract

    Background:
    Lung cancer is an important health problem. To investigate the survival of our patients diagnosed in our hospital with lung cancer and the situations that effect.
    
    Methods:
    Using the data processing and archive system of our hospital , patients were examined who had operated with C34 code in 2013. The rates of survival were calculated using Kaplan-Meier Method and compared with Long-rank method. The influence of age on survival was analysed with Cox’s proportional hazards regression model. For multivariate analysis Cox’s proportional hazards regression model also used. The level of P<0.05 accepted as significant.
    
    Results:
    1563(83.5%) of 1871 patients were male and 308 of the were female and their average age were found as 62.5 years, the average age in male was 62.7 while 61.4 in female. Median age was 62. The rate of M/F was calculated as 5.1, but there were no difference in terms of the average age(p>0.05). We had 16 male and 11 female patients were about 27(1.4%), under the age of 40. As a histological type, 717(38.3%) were squamous carcinoma, 692(37%) were adenocarcinoma, 288(15,4%) were small cell, 174(9.3%) unidentified cell malign carcinoma. While with 42.8% in male squamous carcinoma was frequent, adenocarcinoma with 57.8% in female was frequent. The average survival was calculated as 18 months, median survival as 12 months (95& Cl 11-13 months) and the rate of 2 years survival as 33,4%. While surgical treatment were applied to 380 patients (20.3%), chemotherapy were applied to 1100 patients(58,8%) and palliative care were applied to 302(16,1%) patients. The 2 years survival time was found significantly high in patients received surgical treatment.(73% in spite of 23.3%)(p<0.0001). While the 2 years survival of patients receiving chemotherapy was calculated as 25,6%, the patients receiving palliative care was 20,5%(p=0.08).The median survival time was found 28,4 months in patients receiving surgical treatment, patients receiving chemotherapy 14 months and palliative care was 11.5 months .The patients received neoadjuvan therapy lived 31months. Evaluation made as multivariate analyses; age, gender, with histological type, the tretament variables one by one were found effective on survival as p=0.0001 level.
    
    Conclusion:
    It was obtained that the patients diagnosed with lung cancer in our hospital, after they diagnosed they lived averagely 16 months. The patients received surgical treatment with 73%,with 2 years time survival lived significantly more than the other treatments.